Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma. | J Transl Med | 2022 | 35974375 | PubTator, text mining | PubMed |
| Epigenetics, DNA damage, and aging. | J Clin Invest | 2022 | 35968782 | PubTator, text mining | PubMed |
| Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). | Signal Transduct Target Ther | 2022 | 35963848 | PubTator, text mining | PubMed |
| Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review. | Clin Pharmacol | 2022 | 35958046 | PubTator, text mining | PubMed |
| Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes. | touchREV Endocrinol | 2022 | 35949358 | PubTator, text mining | PubMed |
| The gene dose makes the disease. | Cell | 2022 | 35931018 | PubTator, text mining | PubMed |
| Safety of a feed additive consisting of semduramicin sodium (Aviax 5%) for chickens for fattening (Phibro Animal Health s.a.). | EFSA J | 2022 | 35924189 | PubTator, text mining | PubMed |
| Maternal H3K36 and H3K27 HMTs protect germline development via regulation of the transcription factor LIN-15B. | Elife | 2022 | 35920536 | PubTator, text mining | PubMed |
| Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases. | Curr Opin Struct Biol | 2022 | 35914495 | PubTator, text mining | PubMed |
| A critical appraisal of clinical epigenetics. | Clin Epigenetics | 2022 | 35902960 | PubTator, text mining | PubMed |
| Long-Term Variations in Global Solar Radiation and Its Interaction with Atmospheric Substances at Qomolangma. | Int J Environ Res Public Health | 2022 | 35897279 | PubTator, text mining | PubMed |
| Discovery of a First-in-Class Degrader for Nuclear Receptor Binding SET Domain Protein 2 (NSD2) and Ikaros/Aiolos. | J Med Chem | 2022 | 35895319 | PubTator, text mining | PubMed |
| Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer. | Medicina (Kaunas) | 2022 | 35893093 | PubTator, text mining | PubMed |
| Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases. | Molecules | 2022 | 35889373 | PubTator, text mining | PubMed |
| Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance. | Cells | 2022 | 35883596 | PubTator, text mining | PubMed |
| A Review of Oral Semaglutide Available Evidence: A New Era of Management of Diabetes with Peptide in a Pill Form. | Indian J Endocrinol Metab | 2022 | 35873937 | PubTator, text mining | PubMed |
| Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient. | Open Forum Infect Dis | 2022 | 35873293 | PubTator, text mining | PubMed |
| Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation. | Exp Mol Med | 2022 | 35869366 | PubTator, text mining | PubMed |
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. | Breast Cancer Res | 2022 | 35850772 | PubTator, text mining | PubMed |
| Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB. | EMBO J | 2022 | 35844135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=27